The period for CME/CE credit for this activity has expired.

Current and Emerging Approaches to Promoting Intestinal Adaptation in Short Bowel Syndrome


To complete this activity please view the webcast, complete the demographic questionnaire, CME posttest, and evaluation, and a continuing education certificate will automatically be generated for you to print or save to your computer for your records.

Thank you for your participation.

CME Information

GI Journal Club: Current and Emerging Approaches to Promoting Intestinal Adaptation in Adults With Short Bowel Syndrome

Release date: April 18, 2013
Expiration date: November 30, 2014

This activity and the live CME/CE/CPE symposium on which it is based are supported by an educational grant from NPS Pharmaceuticals, Inc. The live symposium of the same title—presented Monday, February 11, 2013, at Clinical Nutrition Week 2013—was sponsored by the Institute for Medical and Nursing Education, Inc. (IMNE).

Activity Overview and Format

Short bowel syndrome (SBS) is a condition in which functional or anatomical loss of extensive segments of the small intestine results in severely compromised absorptive capacity. SBS significantly reduces quality of life and is associated with catastrophically high costs of care and considerable morbidity and mortality. Varying degrees of intestinal adaptation to SBS can be attained through meticulous multidisciplinary intervention. All healthcare providers (HCPs) managing patients with SBS need to be aware of recent advances in this rapidly developing area to ensure that patients receive the best medical, nutritional, and surgical care based on current evidence.

This webcast features video and audio clips of the faculty synchronized with slide presentations from the live symposium.

Ezra Steiger, MD, FACS, FASPEN —Program Chair
Professor of Surgery
Cleveland Clinic Lerner College of Medicine
Co-Director, Nutrition Support Team
Consultant, General Surgery and Gastroenterology, Digestive Disease Institute
Cleveland Clinic
Cleveland, Ohio

Stephen A McClave, MD
Professor of Medicine
Director of Clinical Nutrition
Division of Gastroenterology, Hepatology, and Nutrition
University of Louisville School of Medicine
Louisville, Kentucky

Stephen JD O’Keefe, MD, MSc, FRCP
Professor of Medicine
Medical Director, Small Intestinal Rehabilitation and Transplant Center
Division of Gastroenterology, Hepatology, and Nutrition
University of Pittsburgh
Pittsburgh, Pennsylvania

Intended Audience
This activity is intended for physicians, nurses, dietitians, pharmacists, educators, researchers, and other HCPs who manage patients with SBS.

Learning Objectives
At the conclusion of this activity, participants should be able to:

  • Define SBS in adults and identify its etiologies and outcomes
  • Summarize current treatment modalities available to manage patients with SBS and the evidence supporting their use
  • Characterize mechanisms involved in intestinal adaptation and therapeutic options available to enhance it

CME Accreditation and Designation Statements
IMNE is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

IMNE designates this enduring activity for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

IMNE is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC’s) Commission on Accreditation.

IMNE designates this educational activity for 1.75 contact hours (0.175 CEUs). Accreditation by the ANCC’s Commission on Accreditation refers to recognition of educational activities and does not imply approval or endorsement of any product.

This program has been approved for continuing professional education credit by the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1.75 continuing professional education units (CPEUs) for completion of this program/material. In order to receive credit, please complete the posttest and fill out the online activity evaluation form.

IMNE is accredited by the Accreditation Council on Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE).

This activity will provide 1.75 contact hours (0.175 CEUs) of credit. The ACPE Universal Program Number is 0383-0000-13-003-H01-P.

Effective January 1, 2013, IMNE is fully integrated into the ACPE/National Association of Boards of Pharmacy® (NABP®) CPE Monitor Program. In order to receive CPE credit for this activity, all pharmacists must enter their date of birth and NABP-ePID number in the spaces allotted on the course evaluation form.

It is the policy of the IMNE to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All individuals involved in planning (eg: faculty, continuing education provider staff, and educational partner staff) are expected to disclose any significant financial relationships with commercial interests over the past 12 months. IMNE also requires that faculty identify and reference off-label product or investigational uses of pharmaceutical agents and medical devices.

In accordance with the ACCME Standards for Commercial Support, parallel documents from other accrediting bodies, and IMNE policy, identification and resolution of conflicts of interest have been made in the form of external peer review of educational content.

The following disclosures have been made.

Stephen A McClave, MD
Consultant: Covidien; Kimberly-Clark Corporation
Speaker Honorarium: Abbott Laboratories; Covidien; Kimberly-Clark Corporation; Nestlé Nutrition
Research Support: Nestlé Nutrition

Dr McClave discloses that he will be discussing off-label uses of the following products: cholestyramine, clonidine, codeine, fludrocortisone, glutamine, loperamide, magnesium sulfate injection, and anyhyrdrous morphine (Paregoric).

Stephen JD O’Keefe, MD, MSc, FRCP
Consultant: NPS Pharamaceuticals, Inc.

Dr O’Keefe discloses that he be discussing off-label use of teduglutide.

Ezra Steiger, MD, FACS, FASPEN
Consultant: Fresenius Kabi; Coram Specialty Infusion Services, an Apria Healthcare Company

Dr Steiger discloses that he will not be discussing any off-label or investigational uses of pharmaceutical products.

IMNE Staff

Amy Groves
Director, Program Development
Ms Groves has nothing to disclose.

Angela McIntosh, PhD
Scientific Director
Dr McIntosh has nothing to disclose.

Marge Tamas
Editorial Manager
Ms Tamas has nothing to disclose.

Steve Weinman, RN, CCMEP
Executive Director
Mr Weinman has nothing to disclose.

CME/CE/CPE Reviewers
Martin Quan, MD
External CME Reviewer
Dr Quan has nothing to disclose.

Darilyn Paul, RN, APRN-BC
External CME Reviewer/Nurse Planner
Ms Paul has nothing to disclose.

Gina Ryan Johnson, PharmD
External CME Reviewer
Dr Johnson has nothing to disclose.

This activity is designed for HCPs for educational purposes. Information and opinions offered by the faculty/presenters represent their own viewpoints. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information.

While IMNE makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should independently and critically assess this activity before applying any information, whether provided here or by others, for any professional use.

Commercial Support Acknowledgment:
This activity is supported by an educational grant from NPS Pharmaceuticals, Inc.

Method of Participation:
To obtain CME credit, each participant should:

  • View the content presented
  • Complete the posttest with a passing score of 70%
  • Complete and submit the CME/CE/CPE demographic and evaluation page
    • Attention pharmacists: In order for us to process CPE for this activity, you must enter your ePID number and month/date of birth in the appropriate areas of the demographic page
  • Print the online CME/CE/CPE certificate

This activity should take approximately 1.75 hours to complete. The expiration date for this activity is November 30, 2014. No credit will be granted after this date.

Technical Requirements:
The following system requirements are recommended for the best presentation viewing experience:


  • Microsoft Windows 2008 (requires the Desktop Experience), Windows 7, Windows Vista, Windows XP, Windows 2003
  • Microsoft Internet Explorer 7.0 or later, Firefox 3.6 or later, or Google Chrome
  • Windows Media Player 9.0 or later
  • Microsoft Silverlight 5.0 or later
  • Broadband Internet connection


  • Mac OS X 10.5.7 or later
  • Safari 4.0 or later or Firefox 3.6 or later
  • Microsoft Silverlight 5.0 or later (viewers are prompted to install this when attempting to view a presentation)
  • Broadband Internet connection (256 Kbps or more)

If you have any questions about viewing the webcast, please contact us.

 I have read and understand the CME Information indexed above.

CME Posttest and Evaluation

    • CME credit is offered upon successful completion of the posttest with a minimum passing score of 70%.
    • After completing the posttest and CME evaluation, a continuing education certificate will automatically be generated and should be printed or saved to your computer for your records.
    • Contact IMNE for questions regarding CME Credits:
    • CME Evaluation - This portion of the activity allows us to evaluate the types of healthcare professionals who are participating in the activity. This information will also be used to develop needs assessments for future educational programs on this topic. Thus, to the best of your ability, please respond with what you feel is the most accurate answer.
    • You must be signed in to in order to participate and receive CME credit.

      New to Click here to register.